Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies ...

DUBLIN, December 18, 2024 -- ( BUSINESS WIRE )-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and ...

ICON was also honoured with a 2024 Scrip award for Best Contract Research Organisation (Full Service Providers). These awards acknowledge the critical role of CROs in delivering specialist outsourced ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Icon ( (ICLR) ) has issued an update.

Mizuho lowered the firm’s price target on Icon (ICLR) to $260 from $295 and keeps an Outperform rating on the shares in conjunction with ...

Co-led by Christy J. Ledford, PhD, professor and vice chair of research in the Department of Family and Community Medicine, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, ...